Esra
@esrajustesra.bsky.social
Stuck on the left end of the curve...
Metavivor is a great place to donate if you'd like to actually support metastatic breast cancer research.
#Stage4NeedsMore
@metavivor.bsky.social
#Stage4NeedsMore
@metavivor.bsky.social
October 8, 2025 at 11:23 PM
Metavivor is a great place to donate if you'd like to actually support metastatic breast cancer research.
#Stage4NeedsMore
@metavivor.bsky.social
#Stage4NeedsMore
@metavivor.bsky.social
www.fiercebiotech.com/cro/spanish-...
MEDSIR will use the Ataraxis Breast platform developed by the New York AI company, which combines pathology results and clinical data to forecast how patients will respond to different treatments.
MEDSIR will use the Ataraxis Breast platform developed by the New York AI company, which combines pathology results and clinical data to forecast how patients will respond to different treatments.
Spanish oncology research group MEDSIR infuses AI into breast cancer trials
Spanish oncology research outfit Medica Scientia Innovation Research (MEDSIR) is infusing artificial intelligence into its breast cancer trials
www.fiercebiotech.com
October 8, 2025 at 11:19 PM
www.fiercebiotech.com/cro/spanish-...
MEDSIR will use the Ataraxis Breast platform developed by the New York AI company, which combines pathology results and clinical data to forecast how patients will respond to different treatments.
MEDSIR will use the Ataraxis Breast platform developed by the New York AI company, which combines pathology results and clinical data to forecast how patients will respond to different treatments.
Reposted by Esra
We start anti-cancer therapies at the highest dose but start supportive care interventions at the lowest dose... WHY? asks @evaschumacherwulf.bsky.social
#MASCC25 #QoL
#MASCC25 #QoL
June 27, 2025 at 8:23 PM
We start anti-cancer therapies at the highest dose but start supportive care interventions at the lowest dose... WHY? asks @evaschumacherwulf.bsky.social
#MASCC25 #QoL
#MASCC25 #QoL
Another very informative webinar on lobular metastatic breast cancer (mILC) by @sherryshenmd.bsky.social Thank you so much for your time! @lobularbca.bsky.social
June 25, 2025 at 9:45 PM
Another very informative webinar on lobular metastatic breast cancer (mILC) by @sherryshenmd.bsky.social Thank you so much for your time! @lobularbca.bsky.social
Reposted by Esra
A new study shows that music therapy is as effective as cognitive behavioral therapy at helping cancer patients and survivors heal emotionally. https://n.pr/45rG55C
The doctor said 'be happy.' Music therapy can help cancer patients do that
A new study shows that music therapy is as effective as cognitive behavioral therapy at helping cancer patients and survivors heal emotionally.
n.pr
June 16, 2025 at 11:39 AM
A new study shows that music therapy is as effective as cognitive behavioral therapy at helping cancer patients and survivors heal emotionally. https://n.pr/45rG55C
A big thank you to Dr. Mouabbi @jamouabbi.bsky.social
and Dr. Shen @sherryshenmd.bsky.social for your time and wonderful presentations on lobular cancer. Thank you
@graspcancer.bsky.social for organizing these sessions!
and Dr. Shen @sherryshenmd.bsky.social for your time and wonderful presentations on lobular cancer. Thank you
@graspcancer.bsky.social for organizing these sessions!
June 11, 2025 at 3:36 PM
A big thank you to Dr. Mouabbi @jamouabbi.bsky.social
and Dr. Shen @sherryshenmd.bsky.social for your time and wonderful presentations on lobular cancer. Thank you
@graspcancer.bsky.social for organizing these sessions!
and Dr. Shen @sherryshenmd.bsky.social for your time and wonderful presentations on lobular cancer. Thank you
@graspcancer.bsky.social for organizing these sessions!
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers | Science Translational Medicine www.science.org/doi/10.1126/...
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers
NR2F2 modulates the ER cistrome, coregulator interactions, and chromatin accessibility to promote endocrine resistance in ER+ breast cancer.
www.science.org
June 9, 2025 at 9:52 PM
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers | Science Translational Medicine www.science.org/doi/10.1126/...
Chemo is like dementors from Harry Potter. It sucks the life out of you. No amount of chocolate helps. 😩
June 9, 2025 at 2:03 PM
Chemo is like dementors from Harry Potter. It sucks the life out of you. No amount of chocolate helps. 😩
Reposted by Esra
Stop by gynecologic oncologist Dr. Alison Schram's poster session on "PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation" TODAY at 9am. #ASCO25. @ascocancer.bsky.social
May 31, 2025 at 1:25 PM
Stop by gynecologic oncologist Dr. Alison Schram's poster session on "PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation" TODAY at 9am. #ASCO25. @ascocancer.bsky.social
Reposted by Esra
"Patient and public involvement in research reporting" - and the case for why we need to do better www.bmj.com/content/389/.... Grateful to have been part of this editorial team with S. Staniszewska, S. Hopewell and R. Chidebe #PatientEngagement #PPI #ConsumerInvolvement
Patient and public involvement in research reporting
More focus needed to improve PPI reporting in research
Patient and public involvement (PPI) has become a key part of health and social care research in many countries with a focus on working with or ...
www.bmj.com
April 10, 2025 at 2:37 PM
"Patient and public involvement in research reporting" - and the case for why we need to do better www.bmj.com/content/389/.... Grateful to have been part of this editorial team with S. Staniszewska, S. Hopewell and R. Chidebe #PatientEngagement #PPI #ConsumerInvolvement
Reposted by Esra
How does SG perform in active BC brain metastases?
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases - PubMed
Central nervous system (CNS) metastases are associated with poor prognosis in patients with metastatic breast cancer (MBC). In this retrospective study, we investigated the activity of sacituzumab gov...
pubmed.ncbi.nlm.nih.gov
April 6, 2025 at 3:10 PM
How does SG perform in active BC brain metastases?
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Starting Xeloda? This is important.
March 13, 2025 at 1:19 AM
Starting Xeloda? This is important.
The first-in-class KIT6 inhibitor PF-07248144 in combination with fulvestrant: "KAT6A inhibition could repress ER gene transcription and overcome ESR1 mutations that promote endocrine therapy resistance."
#metastaticbreastcancer
#stage4needsmore
www.onclive.com/view/pf-0724...
#metastaticbreastcancer
#stage4needsmore
www.onclive.com/view/pf-0724...
PF-07248144 Plus Fulvestrant Is Safe, Active in Pretreated ER+/HER2– Metastatic Breast Cancer
PF-07248144 plus fulvestrant was safe and generated responses in pretreated estrogen receptor–positive, HER2-negative metastatic breast cancer.
www.onclive.com
March 10, 2025 at 3:02 PM
The first-in-class KIT6 inhibitor PF-07248144 in combination with fulvestrant: "KAT6A inhibition could repress ER gene transcription and overcome ESR1 mutations that promote endocrine therapy resistance."
#metastaticbreastcancer
#stage4needsmore
www.onclive.com/view/pf-0724...
#metastaticbreastcancer
#stage4needsmore
www.onclive.com/view/pf-0724...
And you receive a letter starting with "We are sorry to tell you about a privacy event." Seriously?!
February 25, 2025 at 10:19 PM
And you receive a letter starting with "We are sorry to tell you about a privacy event." Seriously?!
Reposted by Esra
Boswellia aka Indian frankincense or olibanum, is a tree native to India.
In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem!
#medsky
www.redjournal.org/article/S036...
In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem!
#medsky
www.redjournal.org/article/S036...
Boswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastases
Radiation necrosis(RN) is a dose-limiting toxicity of stereotactic radiosurgery(SRS)
for brain metastases. Oral corticosteroids are not optimal for long-term management
given multiple side effects. Bo...
www.redjournal.org
February 23, 2025 at 9:16 PM
Boswellia aka Indian frankincense or olibanum, is a tree native to India.
In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem!
#medsky
www.redjournal.org/article/S036...
In a clinical trial, it was safe and effective for radiation induced necrosis of brain metastases which is a common problem!
#medsky
www.redjournal.org/article/S036...
February 19, 2025 at 1:28 PM
😕 Sigh. I look at this and tear up that Ellie is not included 😢
February 17, 2025 at 3:35 PM
😕 Sigh. I look at this and tear up that Ellie is not included 😢